• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾脏病 3 期的风险特征:老年患者与年轻患者比较。

Risk profile in chronic kidney disease stage 3: older versus younger patients.

机构信息

Department of Renal Medicine, Royal Derby Hospital, Derby, UK.

出版信息

Nephron Clin Pract. 2011;119(4):c269-76. doi: 10.1159/000329109.

DOI:10.1159/000329109
PMID:21921639
Abstract

BACKGROUND

The prevalence of chronic kidney disease (CKD) increases with age, but its significance in older patients is uncertain and is regarded by some as part of 'normal aging'. Moreover, subjects ≥75 years are often excluded from research studies. We therefore undertook a prospective study of patients with CKD stage 3 in primary care to compare the risk profile of older versus younger subjects.

METHODS

Subjects with an estimated glomerular filtration rate (eGFR) 59-30 ml/min/1.73 m(2) on two measurements were recruited from 32 primary care practices. Medical history and demographic data were obtained and participants underwent clinical assessment as well as urine and serum biochemistry tests.

RESULTS

1,741 participants were recruited: mean age 72.9 ± 9 years; 60% female; 98% white; 17% diabetic. Mean eGFR was 52.5 ± 10 ml/min/1.73 m(2) and 16.9% had albuminuria. Subjects ≥75 years had a significantly lower eGFR than younger subjects and a higher risk profile characterised by greater albuminuria, more arterial stiffness and higher serum uric acid levels.

CONCLUSION

Older subjects with CKD stage 3 evidenced a higher risk profile for CKD progression and cardiovascular events than younger patients. This implies that CKD is not a benign condition in all elderly patients, but further investigation is required to identify those at greatest risk who may benefit from intervention.

摘要

背景

慢性肾脏病(CKD)的患病率随年龄增长而增加,但在老年患者中的意义尚不确定,有些人认为这是“正常衰老”的一部分。此外,研究通常排除≥75 岁的受试者。因此,我们在初级保健中对 CKD 3 期患者进行了一项前瞻性研究,以比较老年和年轻受试者的风险特征。

方法

在 32 个初级保健机构中,招募了两次估计肾小球滤过率(eGFR)为 59-30ml/min/1.73m(2)的患者。收集病史和人口统计学数据,对参与者进行临床评估以及尿液和血清生化检查。

结果

共招募了 1741 名参与者:平均年龄 72.9±9 岁;60%为女性;98%为白人;17%为糖尿病患者。平均 eGFR 为 52.5±10ml/min/1.73m(2),16.9%有白蛋白尿。≥75 岁的受试者的 eGFR 明显低于年轻受试者,且风险特征更高,表现为白蛋白尿更多、动脉僵硬度更高和血尿酸水平更高。

结论

与年轻患者相比,患有 CKD 3 期的老年患者发生 CKD 进展和心血管事件的风险更高。这意味着 CKD 并非所有老年患者的良性疾病,但需要进一步研究以确定风险最高的患者,他们可能受益于干预。

相似文献

1
Risk profile in chronic kidney disease stage 3: older versus younger patients.慢性肾脏病 3 期的风险特征:老年患者与年轻患者比较。
Nephron Clin Pract. 2011;119(4):c269-76. doi: 10.1159/000329109.
2
Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.肥胖对非糖尿病慢性肾脏病进展的影响:一项回顾性队列研究。
Nephron Clin Pract. 2009;113(1):c16-23. doi: 10.1159/000228071. Epub 2009 Jul 10.
3
Prevalence and risk factors of albuminuria and chronic kidney disease in Chinese population with type 2 diabetes and impaired glucose regulation: Shanghai diabetic complications study (SHDCS).在中国 2 型糖尿病和糖调节受损人群中白蛋白尿和慢性肾脏病的患病率及其危险因素:上海糖尿病并发症研究(SHDCS)。
Nephrol Dial Transplant. 2009 Dec;24(12):3724-31. doi: 10.1093/ndt/gfp349. Epub 2009 Jul 17.
4
Renal disease in adult Nigerians with sickle cell anemia: a report of prevalence, clinical features and risk factors.成年尼日利亚镰状细胞贫血患者的肾脏疾病:患病率、临床特征及危险因素报告
Saudi J Kidney Dis Transpl. 2012 Jan;23(1):171-5.
5
High chronic nephropathy detection yield in CKD subjects identified by the combination of albuminuria and estimated GFR.在白蛋白尿和估计肾小球滤过率联合检测的 CKD 患者中,慢性肾脏病的检出率较高。
Nephrol Dial Transplant. 2012 Feb;27(2):746-51. doi: 10.1093/ndt/gfr360. Epub 2011 Jul 7.
6
Very low-grade albuminuria reflects susceptibility to chronic kidney disease in combination with cardiovascular risk factors.微量白蛋白尿反映了对慢性肾脏病的易感性,同时也存在心血管风险因素。
Hypertens Res. 2010 Jun;33(6):573-8. doi: 10.1038/hr.2010.39. Epub 2010 Apr 9.
7
Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.高血压2型糖尿病患者的慢性肾脏病与心血管风险:基层医疗视角
Nephrol Dial Transplant. 2009 May;24(5):1528-33. doi: 10.1093/ndt/gfn692. Epub 2008 Dec 10.
8
Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.K/DOQI 1-3期慢性肾脏病患者的心血管和肾脏转归:尿白蛋白排泄的重要性
Nephrol Dial Transplant. 2008 Dec;23(12):3851-8. doi: 10.1093/ndt/gfn356. Epub 2008 Jul 18.
9
Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study.比较使用 CKD-EPI 和 MDRD 研究 GFR 估算方程的 CKD 患病率和死亡率风险:AusDiab(澳大利亚糖尿病、肥胖和生活方式)研究。
Am J Kidney Dis. 2010 Apr;55(4):660-70. doi: 10.1053/j.ajkd.2009.12.011.
10
Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study.尿酸作为非糖尿病慢性肾脏病进展的危险因素?轻度至中度肾脏病(MMKD)研究。
Exp Gerontol. 2008 Apr;43(4):347-52. doi: 10.1016/j.exger.2008.01.006. Epub 2008 Jan 26.

引用本文的文献

1
Health-related quality of life, functional impairment and comorbidity in people with mild-to-moderate chronic kidney disease: a cross-sectional study.轻度至中度慢性肾脏病患者的健康相关生活质量、功能障碍及合并症:一项横断面研究。
BMJ Open. 2020 Aug 6;10(8):e040286. doi: 10.1136/bmjopen-2020-040286.
2
CKD: A Call for an Age-Adapted Definition.CKD:呼吁制定适合年龄的定义。
J Am Soc Nephrol. 2019 Oct;30(10):1785-1805. doi: 10.1681/ASN.2019030238. Epub 2019 Sep 10.
3
Associated factors related to chronic kidney disease progression in elderly patients.
与老年患者慢性肾脏病进展相关的因素。
PLoS One. 2019 Jul 23;14(7):e0219956. doi: 10.1371/journal.pone.0219956. eCollection 2019.
4
Nephrology and Public Policy Committee propositions to stimulate research collaboration in adults and children in Europe.肾脏病学和公共政策委员会提议在欧洲促进成人和儿童的研究合作。
Nephrol Dial Transplant. 2019 Sep 1;34(9):1469-1480. doi: 10.1093/ndt/gfz089.
5
The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: A primary care cohort study.胱抑素C检测在慢性肾脏病诊断和管理中的临床效用及成本影响:一项初级保健队列研究
PLoS Med. 2017 Oct 10;14(10):e1002400. doi: 10.1371/journal.pmed.1002400. eCollection 2017 Oct.
6
Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3.在慢性肾脏病3期患者的前瞻性初级保健队列中,成纤维细胞生长因子23、维生素D和甲状旁腺激素与5年预后的相关性。
BMJ Open. 2017 Aug 23;7(8):e016528. doi: 10.1136/bmjopen-2017-016528.
7
Chronic Kidney Disease in Primary Care: Outcomes after Five Years in a Prospective Cohort Study.基层医疗中的慢性肾脏病:一项前瞻性队列研究的五年随访结果
PLoS Med. 2016 Sep 20;13(9):e1002128. doi: 10.1371/journal.pmed.1002128. eCollection 2016 Sep.
8
Where now for proteinuria testing in chronic kidney disease?: Good evidence can clarify a potentially confusing message.慢性肾脏病蛋白尿检测的现状如何?:充分的证据能够厘清一条可能令人困惑的信息。
Br J Gen Pract. 2016 Apr;66(645):215-7. doi: 10.3399/bjgp16X684721.
9
The Association between Polyclonal Combined Serum Free Light Chain Concentration and Mortality in Individuals with Early Chronic Kidney Disease.早期慢性肾脏病患者多克隆联合血清游离轻链浓度与死亡率的关联
PLoS One. 2015 Jul 1;10(7):e0129980. doi: 10.1371/journal.pone.0129980. eCollection 2015.
10
High sodium intake is associated with important risk factors in a large cohort of chronic kidney disease patients.高钠摄入量与一大群慢性肾病患者的重要风险因素相关。
Eur J Clin Nutr. 2015 Jul;69(7):786-90. doi: 10.1038/ejcn.2014.215. Epub 2014 Oct 8.